Procter & Gamble Health Declares Dividend On Strong Q3 Earnings

Procter & Gamble Health Ltd, a leading pharmaceutical and healthcare company, has announced its financial results for the December quarter of FY26, reflecting strong operational performance. The company posted consolidated revenue from operations at 3.74 billion rupees, supported by steady demand across its product portfolio. Net profit stood at 775.9 million rupees, highlighting its ability to sustain profitability despite industry challenges.  

In addition to its earnings, the company declared a dividend of 160 rupees per share, reinforcing its focus on rewarding shareholders. Analysts note that the company’s diversified offerings in healthcare products, operational efficiency, and strong brand presence continue to drive growth momentum.  

Key highlights from the announcement include  

• Consolidated revenue from operations at 3.74 billion rupees in Q3 FY26  
• Net profit reported at 775.9 million rupees for the December quarter  
• Dividend of 160 rupees per share declared  
• Strong demand across healthcare product portfolio supported revenue growth  
• Operational efficiency contributed to sustained profitability  

Industry experts emphasize that Procter & Gamble Health’s results reflect strong fundamentals and adaptability to evolving market conditions. With India’s growing demand for healthcare solutions, the company is expected to maintain steady progress in the coming quarters.  

Sources: Reuters, Economic Times, Business Standard, Mint